A008930 Stock Overview
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Hanmi Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩34,100.00 |
| 52 Week High | ₩56,200.00 |
| 52 Week Low | ₩29,850.00 |
| Beta | 1.1 |
| 1 Month Change | -2.99% |
| 3 Month Change | -17.93% |
| 1 Year Change | -12.56% |
| 3 Year Change | -46.73% |
| 5 Year Change | -47.19% |
| Change since IPO | 7,281.73% |
Recent News & Updates
Recent updates
Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29
Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Jan 31
We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%
Dec 06Shareholder Returns
| A008930 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.6% | -0.2% | 1.0% |
| 1Y | -12.6% | 9.5% | 8.7% |
Return vs Industry: A008930 underperformed the KR Pharmaceuticals industry which returned 9.5% over the past year.
Return vs Market: A008930 underperformed the KR Market which returned 8.7% over the past year.
Price Volatility
| A008930 volatility | |
|---|---|
| A008930 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A008930's share price has been volatile over the past 3 months.
Volatility Over Time: A008930's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 403 | Lim Chong-Yoon | www.hanmiscience.co.kr |
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment.
Hanmi Science Co., Ltd. Fundamentals Summary
| A008930 fundamental statistics | |
|---|---|
| Market cap | ₩2.35t |
| Earnings (TTM) | ₩115.12b |
| Revenue (TTM) | ₩1.25t |
20.1x
P/E Ratio1.9x
P/S RatioIs A008930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A008930 income statement (TTM) | |
|---|---|
| Revenue | ₩1.25t |
| Cost of Revenue | ₩986.45b |
| Gross Profit | ₩261.45b |
| Other Expenses | ₩146.33b |
| Earnings | ₩115.12b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.70k |
| Gross Margin | 20.95% |
| Net Profit Margin | 9.23% |
| Debt/Equity Ratio | 26.7% |
How did A008930 perform over the long term?
See historical performance and comparison